COSCIENS Biopharma Inc. (CSCIF) stock
CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
$6.49+0.00 (0.00%)
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
COSCIENS Biopharma total assets
Total assets on the balance sheet at the end of each period.
COSCIENS Biopharma's total assets was $18.84M at Mar 31, 2026. For fiscal 2025 it was $21.43M, down 38.9% from the year before. The highest annual figure on record is $80.10M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.43M | -38.9% |
| FY2024 | Dec 31, 2024 | $35.07M | +47.7% |
| FY2023 | Dec 31, 2023 | $23.75M | -14.7% |
| FY2022 | Dec 31, 2022 | $27.84M | -65.2% |
| FY2021 | Dec 31, 2021 | $80.10M | +116.5% |
| FY2020 | Dec 31, 2020 | $37.01M | +85.2% |
| FY2019 | Dec 31, 2019 | $19.98M | -20.1% |
| FY2018 | Dec 31, 2018 | $25.01M | +12.7% |
| FY2017 | Dec 31, 2017 | $22.20M | -29.9% |
| FY2016 | Dec 31, 2016 | $31.66M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $18.84M | -39.5% |
| Q4 FY2025 | Dec 31, 2025 | $21.43M | -38.9% |
| Q3 FY2025 | Sep 30, 2025 | $23.86M | -45.5% |
| Q2 FY2025 | Jun 30, 2025 | $27.56M | -44.9% |
| Q1 FY2025 | Mar 31, 2025 | $31.14M | -2.0% |
| Q4 FY2024 | Dec 31, 2024 | $35.07M | +47.7% |
| Q3 FY2024 | Sep 30, 2024 | $43.77M | +3.0% |
| Q2 FY2024 | Jun 30, 2024 | $50.05M | +7.7% |
| Q1 FY2024 | Mar 31, 2024 | $31.79M | -38.0% |
| Q4 FY2023 | Dec 31, 2023 | $23.75M | -14.7% |
| Q3 FY2023 | Sep 30, 2023 | $42.49M | -36.2% |
| Q2 FY2023 | Jun 30, 2023 | $46.48M | -35.3% |
| Q1 FY2023 | Mar 31, 2023 | $51.28M | -32.8% |
| Q4 FY2022 | Dec 31, 2022 | $27.84M | -65.2% |
| Q3 FY2022 | Sep 30, 2022 | $66.61M | -18.8% |
| Q2 FY2022 | Jun 30, 2022 | $71.83M | -14.9% |
| Q1 FY2022 | Mar 31, 2022 | $76.34M | -12.3% |
| Q4 FY2021 | Dec 31, 2021 | $80.10M | +116.5% |
| Q3 FY2021 | Sep 30, 2021 | $82.04M | +154.2% |
| Q2 FY2021 | Jun 30, 2021 | $84.35M | +377.4% |
| Q1 FY2021 | Mar 31, 2021 | $87.01M | +343.0% |
| Q4 FY2020 | Dec 31, 2020 | $37.01M | +85.2% |
| Q3 FY2020 | Sep 30, 2020 | $32.27M | +50.1% |
| Q2 FY2020 | Jun 30, 2020 | $17.67M | -14.9% |
| Q1 FY2020 | Mar 31, 2020 | $19.64M | -21.5% |
| Q4 FY2019 | Dec 31, 2019 | $19.98M | -10.0% |
| Q3 FY2019 | Sep 30, 2019 | $21.50M | -32.1% |
| Q2 FY2019 | Jun 30, 2019 | $20.75M | – |
| Q4 FY2018 | Dec 31, 2018 | $25.01M | – |
| Q4 FY2017 | Dec 31, 2017 | $22.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $31.66M | – |
See a number that looks wrong?